BEI
EDIT icon

Benjamin Edwards Inc’s Editas Medicine EDIT Stock Holding History

Benjamin Edwards Inc’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-24
Closed – – 687
2023
Q1 		$0 Hold
24
– – ﹤0.01% 703
2022
Q4 		$0 Buy
24
+2
+9% +$22 ﹤0.01% 736
2022
Q3 		$0 Sell
22
-1
-4% -$16 ﹤0.01% 711
2022
Q2 		$0 Hold
23
– – ﹤0.01% 720
2022
Q1 		$0 Sell
23
-204
-90% -$3.79K ﹤0.01% 705
2021
Q4 		$6K Sell
227
-269
-54% -$9.26K ﹤0.01% 624
2021
Q3 		$20K Sell
496
-121
-20% -$6.63K 0.01% 401
2021
Q2 		$35K Sell
617
-74
-11% -$2.73K 0.02% 296
2021
Q1 		$29K Buy
691
+98
+17% +$5.58K 0.02% 285
2020
Q4 		$42K Sell
593
-429
-42% -$17.6K 0.03% 256
2020
Q3 		$29K Buy
1,022
+110
+12% +$3.58K 0.02% 256
2020
Q2 		$27K Sell
912
-35
-4% -$915 0.02% 240
2020
Q1 		$19K Buy
947
+39
+4% +$984 0.02% 246
2019
Q4 		$27K Sell
908
-35
-4% -$874 0.06% 153
2019
Q3 		$21K Buy
943
+94
+11% +$2.33K 0.05% 164
2019
Q2 		$21K Buy
849
+266
+46% +$6.35K 0.05% 165
2019
Q1 		$14K Buy
+583
New +$13.2K 0.07% 182

Other funds holding EDIT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Benjamin Edwards Inc's EDIT Position: Q2 2023 in Review

Benjamin Edwards Inc sold out of Editas Medicine (EDIT) in Q2 2023, closing a stake of 24 shares.

Benjamin Edwards Inc first reported a position in EDIT in Q1 2019 and held it in 17 quarters. The position peaked at $42K in Q4 2020. 237 funds tracked by Wall St. Rank hold EDIT as of Q2 2023.

  • Benjamin Edwards Inc reported no remaining Editas Medicine position as of Q2 2023 after selling out during the quarter.
  • Benjamin Edwards Inc sold 24 Editas Medicine shares in Q2 2023.
  • Benjamin Edwards Inc first reported a position in Editas Medicine in Q1 2019 and held it in 17 quarters.
  • Benjamin Edwards Inc's Editas Medicine position peaked at $42K in Q4 2020.
  • 237 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2023.

Based on Benjamin Edwards Inc's 13F filing for Q2 2023, filed 15 Aug 2023.